Comparison of how the the clauses of 21 CFR 310.305(c) are enforced.
Subsection text:
Records and reports concerning adverse drug experiences on marketed prescription drugs for human use without approved new drug applications.
You must be have a paid or trial subscription to view this content
Note: We offer new accounts a one week trial to see how they can reduce costs with better regulatory intelligence.
If you already have an account or want to sign up you can do so at one of the links below
Still skeptical? No worries! Not everything is behind a paywall and you can still: